Study of the Research Medicine CIN-103 in Adults with Irritable Bowel Syndrome with Predominant Diarrhea (IBS-D).
Phase 2
Recruiting
- Conditions
- Irritable Bowel Syndrome with Diarrhea
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-12-01
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- CinPhloro Pharma, LLC
- Target Recruit Count
- 450
- Registration Number
- NCT06153420
- Locations
- 🇺🇸
Digestive Health Specialists - Dothan, Dothan, Alabama, United States
🇺🇸Clinical Research Associates, LLC, Huntsville, Alabama, United States
🇺🇸Elite Clinical Studies LLC, Phoenix, Arizona, United States
© Copyright 2025. All Rights Reserved by MedPath